IHI vs KBWB: Performance, Holdings, Fees & Risk

IHI and KBWB are ETFs, but they can differ materially in exposure, yield, fees and risk. IHI is iShares U.S. Medical Devices ETF, while KBWB is Invesco KBW Bank ETF. IHI is broader by holdings count, with 49 positions versus 29 for KBWB. IHI is more concentrated at the top, based on top-10 holdings weight. Current AlgovestIQ evidence has KBWB ahead on AIQ Score, 62 versus 57.

Market data as of Oct 31, 2026 market close· Fund characteristics as of Oct 31, 2026
IHI
IShares
vs
KBWB
Invesco
IHI
iShares U.S. Medical Devices ETF
Issuer
IShares
Inception
2006-05-01
KBWB
Invesco KBW Bank ETF
Issuer
Invesco
Inception
2011-11-01

What is the main difference between IHI and KBWB?

IHI and KBWB have little in common: 0% of their weight is in the same securities.

Expense ratio
IHI
0.37%
KBWB
0.35%
Lower annual fund costKBWB
Holdings
IHI
49
KBWB
29
Broader reported basketIHI
1Y return
IHI
-11.7%
KBWB
+15.9%
Trailing performanceKBWB
Annualized volatility
IHI
20.5%
KBWB
19.8%
Lower realized volatilityKBWB
MetricIHIKBWB
Fund
Expense ratio0.37%0.35%
Holdings4929
Top-10 concentration74.2%61%
Distribution yieldTrailing 12 months0.48%2.09%
Average volume2,860,7592,057,849
Performance
1Y return-11.7%+15.9%
YTD return-12.1%+5.8%
5Y annualized returnTotal return, distributions reinvested-3.1%+7.3%
Risk
Annualized volatility20.5%19.8%
Max drawdown (1Y)-26.2%-16.4%
Max drawdown (5Y)Total return, distributions reinvested-32.4%-49.3%
Beta0.400.90
Sharpe ratio-0.700.65
Sortino ratio-1.110.91
AlgovestIQ
AIQ Score57/10062/100
AIQ Edge Score6/108/10
Momentum79/10058/100
Risk Resilience70/10072/100

AlgovestIQ AIQ Comparison

iShares U.S. Medical Devices ETF vs Invesco KBW Bank ETF

Data as of Oct 31, 2026· market close· Sector ETFs· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

KBWB leads

KBWB leads by 5 AIQ points, primarily on Value.

Fragile: 2 of 4 evidence groups support KBWB, and its signal state is cleanly positive.

Evidence agreement: 2 of 4Comparison trend: Stable
IHI

iShares U.S. Medical Devices ETF

AIQ Score
57/100
AIQ Edge Score
6/10
KBWB

Invesco KBW Bank ETF

Leads
AIQ Score
62/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors KBWB over IHI, 62 versus 57 as of Oct 31, 2026. KBWB's advantage is driven primarily by stronger value, while IHI holds the stronger momentum profile. KBWB also shows the weaker technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor KBWB today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. KBWB lead: Stable — the AIQ differential has held near 5 points over 30 sessions.

Compare iShares U.S. Medical Devices ETF and Invesco KBW Bank ETF across performance, expense ratio, dividend yield, drawdown, volatility and the Algovestiq AIQ Score.

IHI vs KBWB: which fits what

Each row is settled by a single measure. Where the gap is too small to matter it reads Similar, and no row decides the comparison as a whole.

If you wantIHIKBWBFits
Lower costExpense ratio0.37%0.35%KBWB
Broader diversificationNumber of holdings4929IHI
Lower concentrationWeight of the 10 largest holdings74.2%61%KBWB
Higher incomeTrailing 12-month distribution yield0.48%2.09%KBWB
Smaller drawdownsMax drawdown, 5 years-32.4%-49.3%IHI
Lower volatilityAnnualized volatility, 1 year20.5%19.8%Similar

Similar means the gap is within 0.01 percentage points of expense ratio, 25% more holdings, 3 points of top-10 weight, 0.2 points of yield, 2 points of drawdown or 1 point of volatility. Past drawdowns and volatility describe the funds’ history, not their future.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes for both ETFs.

IHI
-14.6%
KBWB
+42.1%

Total return comparison

Growth of $10,000, distributions reinvested

IHI $8,542 · KBWB $14,213

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare IHI and KBWB against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

IHI advantage
0
KBWB advantage
  • Value31 vs 65
    KBWB +34
  • Momentum79 vs 58
    IHI +21
  • Risk Resilience70 vs 72
    Even
  • Quality59 vs 59
    Even

2 of 4 evidence groups favor KBWB. KBWB’s edge is concentrated in value; IHI keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.

IHI0 AIQ

Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

KBWB+1 AIQ

Largest factor move: Momentum +6

No signal started or stopped since the prior session; its 3 active signals are unchanged.

KBWB's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — IHI and KBWB both carry a full feed there.

The central trade-off

KBWB (Invesco KBW Bank ETF): the stronger current systematic profile, led by value.

IHI (iShares U.S. Medical Devices ETF): the counter-case, on momentum, technicals — but at materially higher volatility, 19.7% against 13.9%.

Fund facts, side by side

Two funds tracking overlapping universes are separated by cost and risk far more than by holdings. Those lead here.

MeasureIHIKBWBWhy it matters
Expense ratio0.37%0.35%Lower is better — it compounds against you every year you hold.
Holdings4929More holdings means broader diversification, not better returns.
Average volume2,860,7592,057,849Liquidity — matters most if you trade size.
Annualized volatility20.5%19.8%Lower is a steadier ride for the same exposure.
Max drawdown (1Y)-26.2%-16.4%The worst peak-to-trough loss over the past year.
Sharpe ratio-0.700.65Return per unit of risk. Higher is better.
Beta0.400.90Sensitivity to the broad market. Neither direction is better — it depends on the role in your portfolio.

Where the exposure actually sits

Sector exposure for each fund, ordered by the size of the difference.

Health Care Equipment99.8% vs 0.0%
Cash and/or Derivatives0.2% vs 0.0%
Financial Services0.0% vs 100.0%
IHIKBWB

How much of the same holdings they own

IHI and KBWB share 0% of their weighted exposure across 0 common holdings.

46 holdings are unique to IHI, and 25 holdings are unique to KBWB. Owning both is genuinely additive — most of the capital sits in different securities.

IHI is the more concentrated of the two: its ten largest positions are 74.18% of the fund, against 60.99% for KBWB (49 holdings vs 29). Concentration cuts both ways — it is what drives outperformance when the top names work, and what makes the drawdown deeper when they do not.

What IHI adds that KBWB doesn’t

HoldingIHIKBWB
ABTABBOTT LABORATORIES18.88%Not held
ISRGINTUITIVE SURGICAL12.88%Not held
SYKSTRYKER9.79%Not held
BDXABECTON DICKINSON5.28%Not held
0Y6X.LMEDTRONIC PLC4.97%Not held
DXCMDEXCOM INC4.82%Not held

What KBWB adds that IHI doesn’t

HoldingKBWBIHI
BACBank of America Corp8.77%Not held
JPMJPMorgan Chase & Co8.54%Not held
WFCWells Fargo & Co8.34%Not held
MSMorgan Stanley7.39%Not held
GSGoldman Sachs Group Inc/The7.19%Not held
STTState Street Corp4.45%Not held

Each list is a fund’s largest positions by weight that the other fund does not hold, or holds at less than half the weight.

IHI vs KBWB: five-year payout growth

IHI grew its split-adjusted payout faster over 2020-2025 — 9.37% a year against KBWB's 5.36%.

Dividend metricIHIKBWB
5Y payout CAGR9.37%5.36%
2020 annual payout$0.136$1.323
2025 annual payout$0.212$1.717
Calendar-year declines21
Peer rank#61 of 138#91 of 138

Split-adjusted annual distributions, 2020–2025. Research as of Sep 19, 2026. Yield and expense ratio above are current values, not part of this window.

AIQ Agreement Matrix

2 of 4 covered evidence groups favor KBWB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreKBWB57 vs 62
FundamentalsNot coveredNot covered
ValuationKBWBValue 31 vs 65
TechnicalsIHIPrice vs 50-day 2.9% vs -3.1%; vs 200-day 1.9% vs 0.3%
Risk ResilienceEvenRisk Resilience 70 vs 72
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IHI and KBWB and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
  • Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on KBWB.

How the comparison changed

120 daily snapshots · Jun 29 – Oct 28

KBWB lead: Stable — the AIQ differential has held near 5 points over 30 sessions.

Jun 29IHI leads above the line · KBWB leads belowOct 28
Today
KBWB +5
57 vs 62
7 sessions ago
KBWB +1
57 vs 58
30 sessions ago
KBWB +7
47 vs 54
90 sessions ago
KBWB +8
50 vs 58

The lead changed hands 2 times in this window, most recently on Oct 19 when KBWB moved ahead of IHI.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

IHIConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only IHI

  • Death Cross Active — bearish, trend, long horizon (1.06%)
  • RSI Overbought — bearish, momentum, short horizon
KBWB

2 bullish / 0 bearish / 1 neutral

Only KBWB

  • Golden Cross Active — bullish, trend, long horizon (2.72%)

Both carry 2 more signals that do not separate them: Bollinger Band Squeeze, MACD Bullish Crossover.

IHI is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

IHINo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.98%, AIQ 0 points).

KBWBDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.86%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IHI closes the Value gap — currently 34 points behind, the largest single contributor to KBWB's edge.
  2. 2IHI's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3KBWB's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Performance

IHI leads 4 of 6 windows
MetricIHIKBWB
1 week (5 sessions)2.3%1.2%
1 month (20 sessions)6.8%2.2%
3 months (63 sessions)3.6%-7%
6 months (126 sessions)4.5%3.6%
Year to date-12.1%5.8%
1 year (252 sessions)-11.7%15.9%

Technicals

IHI has the stronger structure
MetricIHIKBWB
RSI (14)75.359.5
ADX (14)24.823.4
Price vs 50-day2.9%-3.1%
Price vs 200-day1.9%0.3%
Volatility (1M, annualized)19.7%13.9%

Risk

Split
MetricIHIKBWB
Beta0.40.9
Sharpe ratio-0.70.65
Sortino ratio-1.110.91
Max drawdown-26.2%-16.4%
Current drawdown-15.3%-10.6%
Annualized volatility20.5%19.8%
Value at risk (95%)-2.1%-2.2%

Straight answers

Short answers to the questions fund investors ask about this pair, from the figures above.

What is the difference between IHI and KBWB?

IHI and KBWB have little in common: 0% of their weight is in the same securities.

How much do IHI and KBWB overlap?

IHI and KBWB share 0% of their weighted exposure across 0 common holdings. 46 holdings are unique to IHI, and 25 holdings are unique to KBWB. Owning both is genuinely additive — most of the capital sits in different securities.

Which ETF is more diversified, IHI or KBWB?

IHI holds more positions: 49 versus 29 for KBWB.

Which has the lower expense ratio?

KBWB has the lower expense ratio, 0.35% a year against 0.37% for IHI.

Which ETF has the higher distribution yield?

KBWB, with a trailing 12-month distribution yield of 2.09% against 0.48% for IHI.

Which ETF has been more volatile?

Their volatility over the past year is similar: 20.5% annualized for IHI and 19.8% for KBWB.

Which ETF has had the smaller drawdown?

IHI fell less from peak to trough over the past five years: -32.4% against -49.3% for KBWB.

Compare IHI and KBWB with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.